Histidine decarboxylase but not histamine receptor 1 or 2 deficiency protects from K/BxN serum-induced arthritis

International Immunology

Volumn 21, Issue 11, 2009, Pages 1263-1268

  Rajasekaran, Narendiran ^a,f   Solomon, Samuel ^b   Watanabe, Takeshi ^c   Ohtsu, Hiroshi ^d   Gajda, Mieczyslaw ^e   Bräuer, Rolf ^e   Illges, Harald ^a  

^a BONN RHEIN SIEG UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c KYUSHU UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e JENA UNIVERSITY HOSPITAL   (Germany)

^f STANFORD UNIVERSITY   (United States)

Author keywords

Histamine receptor; Histidine decarboxylase; K BxN mouse model

Indexed keywords

HISTAMINE RECEPTOR; HISTAMINE RECEPTOR 1; HISTAMINE RECEPTOR 2; HISTIDINE DECARBOXYLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME DEFICIENCY; HISTOCHEMISTRY; JOINT DESTRUCTION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; HISTAMINE; HISTIDINE DECARBOXYLASE; MAST CELLS; MICE; MICE, KNOCKOUT; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2;

EID: 71049186778     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp092     Document Type: Article

References (31)

1. Kouskoff, V., Korganow, A. S., Duchatelle, V., Degott, C., Benoist, C. and Mathis, D. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87:811.
2. Matsumoto, I., Staub, A., Benoist, C. and Mathis, D. 1999. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286:1732.
3. Wipke, B. T. and Allen, P. M. 2001. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167:1601.
4. Wipke, B. T., Wang, Z., Nagengast, W., Reichert, D. E. and Allen, P. M. 2004. Staging the initiation of autoantibody-induced arthritis: A critical role for immune complexes. J. Immunol. 172:7694.
5. Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D. and Brenner, M. B. 2002. Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Science 297:1689.
6. Ji, H., Ohmura, K., Mahmood, U. et al. 2002. Arthritis critically dependent on innate immune system players. Immunity 16:157.
7. Solomon, S., Kolb, C., Mohanty, S. et al. 2002. Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35). Eur. J. Immunol. 32:644.
8. Kneilling, M., Hultner, L., Pichler, B. J. et al. 2007. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum. 56:1806.
9. Wooley, D. E. 1995. Mast cells in the rheumatoid lesion - ringleaders or innocent bystanders? Ann. Rheum. Dis. 54:533.
10. Baumann, U., Chouchakova, N., Gewecke, B. et al. 2001. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung. J. Immunol. 167:1022.
11. Baumann, U., Kohl, J., Tschernig, T. et al. 2000. A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction. J. Immunol. 164:1065.
12. Chiba, S. and Tsukada, M. 1997. Mechanisms for histamine H1 receptor-mediated vasodilation in isolated canine lingual arteries. Eur. J. Pharmacol. 329:63.
13. Parsons, G. H., Villablanca, A. C., Brock, J. M. et al. 1992. Bronchial vasodilation by histamine in sheep: Characterization of receptor subtype. J. Appl. Physiol. 72:2090.
14. Dachman, W. D., Bedarida, G., Blaschke, T. F. and Hoffman, B. B. 1994. Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. J. Allergy Clin. Immunol. 93:606.
15. Chiba, S. and Tsukada, M. 1991. Histamine-induced vasodilations mediated by H1- and H2-receptors in isolated rat common carotid arteries. Heart Vessels 6:185.
16. Ohtsu, H., Tanaka, S., Terui, T. et al. 2001. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 502:53.
17. Inoue, I., Yanai, K., Kitamura, D. et al. 1996. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc. Natl Acad. Sci. USA 93:13316.
18. Kobayashi, T., Tonai, S., Ishihara, Y., Koga, R., Okabe, S. and Watanabe, T. 2000. Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. J. Clin. Investig. 105:1741.
19. Solomon, S., Rajasekaran, N., Jeisy-Walder, E., Snapper, S. B. and Illges, H. 2005. A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis. Eur. J. Immunol. 35: 3064.
20. De Bandt, M., Ben Mahdi, M. H., Ollivier, V. et al. 2003. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J. Immunol. 171:4853.
21. Gordon, J. R. and Galli, S. J. 1991. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mousemast cells stimulated via the Fc epsilon RI. Amechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J. Exp. Med. 174:103.
22. Hollenberg, S. M., Cunnion, R. E. and Parrillo, J. E. 1991. The effect of tumor necrosis factor on vascular smooth muscle. In vitro studies using rat aortic rings. Chest 100:1133.
23. Johns, D. G. and Webb, R. C. 1998. TNF-alpha-induced endothelium-independent vasodilation: A role for phospholipase A2-dependent ceramide signaling. Am. J. Physiol. 275:H1592.
24. Zhang, Y., Ramos, B. F. and Jakschik, B. A. 1992. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258:1957.
25. Watanabe, N., Akikusa, B., Park, S. Y. et al. 1999. Mast cells induce autoantibody-mediated vasculitis syndrome through tumor necrosis factor production upon triggering Fcgamma receptors. Blood 94:3855.
26. Hill, S. J., Ganellin, C. R., Timmerman, H. et al. 1997. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 49:253.
27. Hill, S. J. 1990. 1990. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42:45.
28. Del Valle, J. and Gantz, I. 1997. Novel insights into histamine H2 receptor biology. Am. J. Physiol. 273:G987.
29. Leurs, R., Smit, M. J. and Timmerman, H. 1995. Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther. 66:413.
30. Ikawa, Y., Suzuki, M., Shiono, S. et al. 2005. Histamine H4 receptor expression in human synovial cells obtained from patients suffering from rheumatoid arthritis. Biol. Pharm. Bull. 28: 2016.
31. Ohki, E., Suzuki, M., Aoe, T., Ikawa, Y., Negishi, E. and Ueno, K. 2007. Expression of histamine H4 receptor in synovial cells from rheumatoid arthritic patients. Biol. Pharm. Bull. 30:2217.